Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Neutropenia
Interventions: BIOLOGICAL: Empegfilrastim 6 mg|BIOLOGICAL: Filgrastim|BIOLOGICAL: Placebo №1|BIOLOGICAL: Placebo №2|BIOLOGICAL: Empegfilrastim 7.5 mg
Sponsor: Biocad